Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-03-25 Sale |
2024-08-14 4:05 pm |
Q32 Bio Inc. | QTTB | TZIANABOS ARTHUR Director |
265 | $24.2 | $6,413 | 7,983 (Direct) |
View |
2024-01-09 Sale |
2024-02-15 4:33 pm |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director |
13,037 | $0.5711 | $7,445 | 148,498 (Direct) |
View |
2023-01-09 Sale |
2023-01-11 4:05 pm |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director |
10,616 | $1.3905 | $14,762 | 108,395 (Direct) |
View |
2022-01-05 Sale |
2022-01-12 4:05 pm |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR President & CEO |
5,354 | $3.7802 | $20,239 | 114,151 (Direct) |
View |
2021-02-19 Sale |
2021-02-23 5:28 pm |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
10,000 | $60.67 | $606,652 | 13,447 (Direct) |
View |
2020-11-23 Sale |
2020-11-25 5:09 pm |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
20,000 | $46.03 | $920,566 | 23,447 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-20 Option Award |
2025-03-20 6:18 pm |
N/A 2035-03-19 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Interim Executive Chair |
122,651 | $0 | 122,651 (Direct) |
View |
2025-02-24 Option Award |
2025-02-27 06:01 am |
N/A 2026-04-22 |
Q32 Bio Inc. | QTTB | TZIANABOS ARTHUR Director |
38,441 | $0 | 38,441 (Direct) |
View |
2024-03-25 Exercise |
2024-08-14 4:05 pm |
N/A N/A |
Q32 Bio Inc. | QTTB | TZIANABOS ARTHUR Director |
1,095 | $0 | 7,983 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:19 pm |
N/A 2034-06-04 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
7,639 | $0 | 7,639 (Direct) |
View |
2024-03-25 Option Award |
2024-03-27 5:43 pm |
N/A 2034-03-24 |
Q32 Bio Inc. | QTTB | TZIANABOS ARTHUR Director |
12,767 | $0 | 12,767 (Direct) |
View |
2024-01-01 Exercise |
2024-02-15 4:33 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director |
33,420 | $0 | 148,498 (Direct) |
View |
2024-02-13 Exercise |
2024-02-15 4:17 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
31,739 | $2.19 | 31,739 (Direct) |
View |
2024-02-13 Exercise |
2024-02-15 4:17 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
31,739 | $0 | 31,739 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 6:26 pm |
N/A 2033-06-12 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
19,441 | $0 | 19,441 (Direct) |
View |
2023-06-14 Option Award |
2023-06-15 6:14 pm |
N/A 2033-06-14 |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director |
23,000 | $0 | 23,000 (Direct) |
View |
2023-01-01 Exercise |
2023-01-04 4:36 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director |
33,000 | $0 | 172,151 (Direct) |
View |
2022-11-30 Equity Swap |
2022-12-02 4:51 pm |
N/A N/A |
Akouos Inc. | AKUS | TZIANABOS ARTHUR Director |
26,930 | $0 | 0 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 5:04 pm |
N/A 2032-06-22 |
Akouos Inc. | AKUS | TZIANABOS ARTHUR Director |
16,000 | $0 | 16,000 (Direct) |
View |
2022-06-07 Option Award |
2022-06-08 5:00 pm |
N/A 2032-06-06 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
21,000 | $0 | 21,000 (Direct) |
View |
2022-02-24 Option Award |
2022-02-28 4:05 pm |
N/A 2032-02-24 |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR President & CEO |
408,000 | $0 | 408,000 (Direct) |
View |
2022-01-01 Exercise |
2022-01-12 4:05 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR President & CEO |
13,860 | $0 | 114,151 (Direct) |
View |
2021-06-08 Option Award |
2021-06-25 5:04 pm |
N/A 2031-06-07 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
11,650 | $0 | 11,650 (Direct) |
View |
2021-06-24 Option Award |
2021-06-25 4:34 pm |
N/A 2031-06-23 |
Akouos Inc. | AKUS | TZIANABOS ARTHUR Director |
16,000 | $0 | 16,000 (Direct) |
View |
2021-02-19 Exercise |
2021-02-23 5:28 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
10,000 | $2.19 | 13,447 (Direct) |
View |
2021-02-19 Exercise |
2021-02-23 5:28 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
10,000 | $0 | 13,447 (Direct) |
View |
2021-02-05 Option Award |
2021-02-09 4:21 pm |
N/A 2031-02-05 |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR President & CEO |
296,000 | $0 | 296,000 (Direct) |
View |
2020-11-23 Exercise |
2020-11-25 5:09 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
20,000 | $2.19 | 23,447 (Direct) |
View |
2020-11-23 Exercise |
2020-11-25 5:09 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
20,000 | $0 | 23,447 (Direct) |
View |
Ownership |
2020-06-25 7:12 pm |
N/A N/A |
Akouos Inc. | AKUS | TZIANABOS ARTHUR Director |
0 | $0 | 39,030 (Direct) |
View |
2020-06-03 Option Award |
2020-06-05 5:32 pm |
N/A 2030-06-02 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
14,777 | $0 | 14,777 (Direct) |
View |